Exchange: NASDAQ
Industry: Health Care Equipment & Services
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
27,033,600 | 26,999,400 | 27,692,500 | 12,132,600 | 12,101,400 |
Cost of Goods Sold (COGS) incl. D&A |
24,782,800 | 24,864,900 | 25,579,600 | 11,300,600 | 11,297,600 |
COGS excluding D&A |
24,202,200 | 24,726,300 | 24,974,400 | 11,235,600 | 11,231,700 |
Depreciation & Amortization Expense |
580,600 | 138,600 | 605,200 | 65,000 | 65,900 |
Gross Income |
2,250,800 | 2,134,500 | 2,112,900 | 832,000 | 803,800 |
SG&A Expense |
1,325,500 | 1,336,000 | 1,580,800 | 267,500 | 228,900 |
Research & Development |
NA | 0 | 0 | 0 | 0 |
Other SG&A |
1,325,500 | 1,336,000 | 1,580,800 | 267,500 | 228,900 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
0 | 0 | 0 | 0 | 0 |
Non Operating Income/Expense |
500 | 0 | 0 | 0 | 4,600 |
Equity in Affiliates (Pretax) |
5,500 | 5,100 | 4,300 | 0 | 0 |
Interest Expense |
155,900 | 155,900 | 175,200 | 132,000 | 115,400 |
Gross Interest Expense |
155,900 | 155,900 | 175,200 | 132,000 | 115,400 |
Pretax Income |
780,000 | 649,100 | 363,500 | 434,800 | 464,100 |
Income Tax |
231,100 | 257,700 | 192,600 | 167,000 | 173,700 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
548,900 | 391,400 | 170,900 | 267,800 | 290,400 |
Minority Interest Expense |
17,200 | 0 | 0 | 0 | 0 |
Net Income |
531,700 | 391,400 | 170,900 | 267,800 | 290,400 |
Extraordinaries & Discontinued Operations |
-27,600 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
-27,600 | 0 | 0 | 0 | 0 |
Net Income After Extraordinaries |
559,299 | 391,400 | 170,900 | 267,800 | 290,400 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
531,700 | 391,400 | 170,900 | 267,800 | 290,400 |
Operational EPS |
0.64 | 0.47 | 0.21 | 0.55 | 0.58 |
EPS (basic) |
0.62 | 0.48 | 0.21 | 0.55 | 0.58 |
EBITDA |
1,505,900 | 937,100 | 1,137,300 | 629,500 | 640,800 |
Depreciation & Amortization Expense |
580,600 | 138,600 | 605,200 | 65,000 | 65,900 |
Common Shares Outstanding |
826,393 | 829,600 | 823,900 | 489,700 | 505,000 |
Basic Shares Outstanding |
813,064 | 812,900 | 807,800 | 485,300 | 500,900 |
Diluted Shares Outstanding |
826,393 | 829,600 | 823,900 | 489,700 | 505,000 |
Diluted EPS after Extraordinary Items |
0.61 | 0.47 | 0.21 | 0.55 | 0.58 |
Discont. Operations Per Share |
-0.03 | 0 | 0 | 0 | 0 |
Continued operations EPS |
0.65 | 0.48 | 0.21 | 0.55 | 0.58 |
*Figures in thousands of U.S. Dollars except shares outstanding.
